Market Cap 43.50M
Revenue (ttm) 168.90M
Net Income (ttm) -4.56M
EPS (ttm) N/A
PE Ratio 89.33
Forward PE N/A
Profit Margin -2.70%
Debt to Equity Ratio 0.00
Volume 6,046
Avg Vol 886,044
Day's Range N/A - N/A
Shares Out 16.60M
Stochastic %K 2%
Beta 0.33
Analysts Strong Buy
Price Target N/A

Company Profile

Binah Capital Group, Inc., together with its subsidiaries, operates in the wealth management industry. The company provides access to stock, bond, exchange-traded fund, and options execution services; and research, compliance, supervision, and accounting and related services for financial advisors. It also offers mutual funds and insurance products, as well as alternative investments, such as non-traded real estate investment trusts, unit trusts, and fixed and variable annuities. The company was...

Industry: Asset Management
Sector: Financial Services
Phone: 212 404 7002
Address:
80 State Street, Albany, United States
Bazzzigar
Bazzzigar Jan. 3 at 7:32 PM
$BCG ASST
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 2 at 4:28 PM
$BCG RSI: 52.15, MACD: 0.1062 Vol: 0.23, MA20: 2.39, MA50: 2.11 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
misterbond007
misterbond007 Dec. 31 at 8:30 PM
0 · Reply
ChartChartist
ChartChartist Dec. 31 at 6:59 PM
$BCG yes
0 · Reply
topstockalerts
topstockalerts Dec. 31 at 5:40 PM
$BCG Is it going higher?
0 · Reply
misterbond007
misterbond007 Dec. 30 at 11:28 PM
0 · Reply
misterbond007
misterbond007 Dec. 30 at 11:26 PM
0 · Reply
LittleMermaids
LittleMermaids Dec. 30 at 7:10 PM
$BCG 👀
0 · Reply
LeroySylva521
LeroySylva521 Dec. 30 at 6:05 PM
$BCG Ownership concentration is the real signal. Institutional control rose from ~1.1–1.6% to ~3.1% (~2x increase). UBS expanded exposure ~206% QoQ, while Vanguard and Geode continued scaling. At ~$1.50, total institutional capital deployed now exceeds $6.5M. Higher concentration tightens supply and historically precedes upside volatility. A $5 target still implies ~+233% upside without extreme assumptions. company name in bio 🚀
0 · Reply
Ron_Burn
Ron_Burn Dec. 30 at 2:56 PM
$BCG she's coming back home
0 · Reply
Latest News on BCG
Binah Capital Group Reports Second Quarter 2025 Results

Aug 13, 2025, 5:40 PM EDT - 5 months ago

Binah Capital Group Reports Second Quarter 2025 Results


Binah Capital Group Reports First Quarter 2025 Results

May 15, 2025, 5:36 PM EDT - 8 months ago

Binah Capital Group Reports First Quarter 2025 Results


Bazzzigar
Bazzzigar Jan. 3 at 7:32 PM
$BCG ASST
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 2 at 4:28 PM
$BCG RSI: 52.15, MACD: 0.1062 Vol: 0.23, MA20: 2.39, MA50: 2.11 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
misterbond007
misterbond007 Dec. 31 at 8:30 PM
0 · Reply
ChartChartist
ChartChartist Dec. 31 at 6:59 PM
$BCG yes
0 · Reply
topstockalerts
topstockalerts Dec. 31 at 5:40 PM
$BCG Is it going higher?
0 · Reply
misterbond007
misterbond007 Dec. 30 at 11:28 PM
0 · Reply
misterbond007
misterbond007 Dec. 30 at 11:26 PM
0 · Reply
LittleMermaids
LittleMermaids Dec. 30 at 7:10 PM
$BCG 👀
0 · Reply
LeroySylva521
LeroySylva521 Dec. 30 at 6:05 PM
$BCG Ownership concentration is the real signal. Institutional control rose from ~1.1–1.6% to ~3.1% (~2x increase). UBS expanded exposure ~206% QoQ, while Vanguard and Geode continued scaling. At ~$1.50, total institutional capital deployed now exceeds $6.5M. Higher concentration tightens supply and historically precedes upside volatility. A $5 target still implies ~+233% upside without extreme assumptions. company name in bio 🚀
0 · Reply
Ron_Burn
Ron_Burn Dec. 30 at 2:56 PM
$BCG she's coming back home
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 30 at 2:37 PM
0 · Reply
WeavingWoodcarve
WeavingWoodcarve Dec. 26 at 5:25 PM
$BCG Trading behavior shows investors weighing repeatability of results above expansion claims. Balance sheet resilience remains an underappreciated swing factor. Risk compresses once delivery patterns become predictable. Execution quality will determine whether momentum is sustainable.
0 · Reply
DylanGFM
DylanGFM Dec. 19 at 10:13 PM
$BCG Not sleeping on this one I got high expectations for this
0 · Reply
Ron_Burn
Ron_Burn Dec. 15 at 12:45 PM
$BCG buy zone here
0 · Reply
TheRoaringBunny
TheRoaringBunny Dec. 1 at 2:03 AM
Market Red? PRPH CEO Ted Karkus - the Chuck Norris of Pharma has the green candles $PRPH CEO Ted Karkus in a nutshell: 2009 proxy war → seized control → sold Cold-EEZE for $50M → turned dying OTC company into $200M+ COVID lab beast → bought Nebula Genomics → built massive AI-ready whole-genome database → now dropping cancer tests with Abu Dhabi partners. Before that he flipped ID Biomedical $25M$1.4B exit to GSK. Man’s a walking 10-100x machine. Ted Karkus facts: • Short sellers don’t cover $PRPH - they just change their names and move countries. • Ted doesn’t file 13Ds — the SEC filings file Ted. • Market cap doesn’t measure Ted Karkus — Ted Karkus measures market cap… and finds it lacking. Webinar Monday AH. $9M cap with $50M+ coming. Sleepers gonna cry. 🚀 $PRPH $LFS $GREE $BCG $HXHX
1 · Reply
TheRoaringBunny
TheRoaringBunny Nov. 28 at 4:32 PM
$PRPH Fresh News Blast: Biotech Beast @ $0.20 Primed for Overnight Triple Immediate Catalysts for 3x Gap-Up: BTC treasury live (Nov 24th vote passed 63%+) – scooping BTC dips. Nasdaq compliance sealed, tiny float screaming squeeze. MONDAY DEC 1 CEO webinar deep-dive (4:15pm ET) – expect cash/M&A/BE-Smart bombshells to ignite shorts. Monday after hours massive runner?!? Hot off the press: Nov 19 Q3 results dropped – inked M&A talks for “multiples” of current price, unlocking hidden value in genomics pipeline. Crown Medical locked as special counsel for $50M+ COVID receivables chase – first payout already Q3, Q4/Q1 bombshell incoming (non-dilutive 5-6x mkt cap rocket). BE-Smart esophageal cancer test commercialization accelerating post-Oct validation pub & Aug patent – $7-14B TAM launch. From $0.20 to $0.60+? This pops HARD pre-market Monday and runs like an escaped convict. Loading heavy. 🚀 Not advice, DYOR. $BNAI $HXHX $BCG $CYPH
0 · Reply
funnymoney90210
funnymoney90210 Nov. 27 at 9:41 PM
0 · Reply
YungnredE
YungnredE Nov. 26 at 4:31 PM
$BCG I don't think this is dropping anytime soon... for the daily that is
0 · Reply
HighReturnStocks
HighReturnStocks Nov. 26 at 4:21 PM
$BCG 136% so far, still holding half my shares been trimming on the way up. $CLSK adds in the low $9.00's paying off big too. $IMCC is also starting to rocket :)
0 · Reply
fullmetalll
fullmetalll Nov. 26 at 3:19 PM
$APLD Things are going well, $BCG is very interesting, to late?
0 · Reply
Ron_Burn
Ron_Burn Nov. 26 at 3:13 PM
$BCG 😁
0 · Reply
HighReturnStocks
HighReturnStocks Nov. 25 at 8:24 PM
$BCG 113% and climbing! $CLSK adds last week paying off! Also liking $IMCC right now
0 · Reply